Biohaven Ltd.
Statements
Cash Flow
Biohaven Ltd. (BHVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -85 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q1 18 | Q4 18 | Q1 19 | Q4 19 | Q1 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.7 | -82 | -108 | -47 | -249 | -151 | -505 | -206 | -35 | -44 | -33 | -59 | -68 | -96 | -75 | -78 | -44 | -95 | -115 | -103 | -168 | -141 | -171 | -165 | -168 | -146 | -131 | -150 | -85 | -511 | |
| 0.0 | 0.0 | 0.0 | – | 0.0 | – | 9.4 | 5.1 | 0.2 | 0.2 | 0.7 | 0.3 | 0.4 | 0.4 | 0.3 | 1.6 | 1.8 | 1.5 | 1.9 | 1.4 | 2.0 | 2.0 | 2.5 | 2.2 | 2.0 | 3.1 | 2.6 | 2.4 | 2.3 | 10 | |
| 1.9 | 3.1 | 12 | 7.3 | 45 | 17 | 33 | 49 | 19 | 15 | 13 | 40 | 21 | 17 | 116 | 3.8 | 4.7 | 4.5 | 16 | 35 | 12 | 12 | 13 | 53 | 21 | 22 | 17 | 28 | 19 | 86 | |
| – | – | – | – | – | – | – | – | – | 19 | 23 | 78 | 78 | 17 | 126 | 3.4 | 3.4 | 3.4 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.7 | 4.2 | -6.9 | -2.5 | -1.7 | 6.5 | -4.0 | -18 | -0.9 | -8.7 | 6.6 | -3.7 | 20 | -44 | -1.0 | -11 | 41 | 2.8 | -8.7 | 26 | -23 | 21 | -6.0 | -4.4 | 19 | -3.0 | -9.8 | -53 | 17 | -49 | |
| 0.0 | 0.4 | 3.8 | 1.0 | 1.1 | 1.0 | 0.3 | 1.2 | 0.4 | 0.0 | 0.2 | 0.2 | 36 | 4.5 | 0.3 | 0.7 | 0.6 | 1.2 | 0.5 | 0.4 | 2.9 | 0.6 | 0.0 | 0.5 | 0.2 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | |
| -1.6 | -1.7 | -7.2 | -1.0 | -1.0 | -23 | -245 | 120 | 0.6 | 0.0 | -0.2 | -0.2 | -36 | -4.5 | -264 | -1.1 | 76 | 59 | -3.9 | 34 | -98 | -93 | -88 | 165 | -16 | 165 | -14 | 15 | 45 | 211 | |
| – | – | – | – | – | – | – | – | – | – | -31 | – | – | – | – | – | – | – | – | – | – | – | 12 | – | – | – | 1.8 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 70 | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | – | 0.0 | 0.0 | – | – | – | |
| 38 | 56 | 247 | 1.1 | 378 | 286 | 502 | 421 | 38 | 315 | -252 | 23 | 87 | 128 | 530 | 27 | -20 | -40 | 245 | 3.4 | 321 | 80 | 273 | 0.4 | 250 | 0.1 | 189 | 179 | 3.8 | 372 | |
| 29 | -27 | 131 | -47 | 100 | 112 | -295 | 335 | 4.0 | 271 | -286 | -36 | -17 | 27 | 191 | -52 | 11 | -76 | 126 | -65 | 55 | -154 | 15 | 0.1 | 66 | 19 | 44 | 44 | -36 | 72 | |
| -7.7 | -82 | -112 | -48 | -250 | -152 | -506 | -207 | -35 | -44 | -33 | -59 | -104 | -100 | -76 | -78 | -45 | -96 | -115 | -103 | -171 | -142 | -171 | -166 | -168 | -146 | -131 | -150 | -86 | -512 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.